The STD threat most men are ignoring is the silent, symptom-free spread of infections like chlamydia and gonorrhea that quietly scar the reproductive tract, and it's getting worse because the bacteria causing them are running out of antibiotics that can reliably kill them.
Most men don't think about STDs until something goes wrong. And by the time something goes wrong, the damage is often already done.
I spent a few months digging into the research on sexually transmitted infections and male fertility. What I found surprised me. The real threat isn't just the infection itself. It's the fact that we are running out of effective treatments. And most men have no idea this is happening.
The World Health Organization estimates that STDs contribute to roughly 15% of male infertility cases worldwide. That number is conservative. It only counts cases where an infection is diagnosed. The problem is that the majority of STDs in men are asymptomatic. You can carry chlamydia for months, even years, without noticing a thing. Meanwhile, the damage accumulates below the surface: inflammation, scarring, blockages in the epididymis or vas deferens. By the time a man tries to conceive and gets tested, the repair window may have already closed.
That is the current picture. The future picture looks worse.
How STDs Actually Damage Sperm Production
Let's start with the mechanics, because most men's health blogs skip this part.
When an STD like Chlamydia trachomatis or Neisseria gonorrhoeae enters the male reproductive tract, it does not just hang out in the urethra. It can travel up into the epididymis, the coiled tube behind each testicle where sperm mature and gain motility. The body's immune response floods the area with white blood cells. That inflammation, called epididymitis, causes swelling, scarring, and eventually blockages. Sperm are still produced, but they never make it out.
A 2019 review in Human Reproduction Update analyzed 20 years of data and found that men with a history of chlamydia infection had significantly lower sperm motility and higher DNA fragmentation rates, even after successful antibiotic treatment. The damage was not just mechanical. The bacteria triggered an immune response that continued to attack sperm cells long after the infection cleared.
Gonorrhea is more aggressive. It causes more intense inflammation and can lead to bilateral epididymitis - both sides are affected. If left untreated long enough, it can cause complete obstruction of the epididymal ducts. That is permanent without surgical intervention, and even surgery does not always restore fertility.
HPV is the overlooked one. Most men clear HPV infections on their own within two years. But research from the University of Buenos Aires found that men with persistent HPV infections had sperm with significantly higher rates of DNA fragmentation and abnormal morphology. The virus appears to integrate into sperm cells and disrupt their ability to fertilize an egg. Unlike bacterial STDs, there is no antibiotic for HPV. There is a vaccine. That matters more than most men realize.
The Antibiotic Resistance Problem Nobody Is Talking About
Here is where the speculative future starts to feel real.
Neisseria gonorrhoeae has been developing resistance to every class of antibiotics we have thrown at it. Penicillin worked until the 1970s. Then tetracycline. Then fluoroquinolones. As of 2025, the CDC recommends only one class of antibiotics as a reliable first-line treatment for gonorrhea: ceftriaxone, a third-generation cephalosporin. That is it. One drug standing between millions of men and permanent reproductive damage.
In 2023, the UK Health Security Agency reported a 21% increase in gonorrhea cases compared to the previous year and detected strains with reduced susceptibility to ceftriaxone. Japan and Australia have already reported treatment failures. The World Health Organization has listed ceftriaxone-resistant gonorrhea as a high-priority pathogen for new antibiotic development. But new antibiotics are not coming fast enough. The pharmaceutical pipeline for Gram-negative bacteria like Neisseria has been dry for decades.
Chlamydia is less of an immediate concern for full resistance, but it is not immune. Chlamydia trachomatis has shown increasing resistance to azithromycin in several studies, including a 2021 analysis in Clinical Infectious Diseases that found treatment failure rates as high as 13% in some populations. The standard dual therapy of doxycycline plus azithromycin still works for most, but that margin is shrinking.
What does this mean for male fertility? If you project current resistance trends forward ten years, a significant percentage of gonorrhea cases will be difficult or impossible to treat with existing drugs. The longer an infection goes untreated - whether because the man does not know he has it or because the antibiotics fail - the more time the bacteria have to cause scarring and blockages. We could see a measurable increase in STD-related male infertility within a generation.
HPV Vaccination for Men: The Missed Opportunity
Here is the contrarian part of this conversation. We spend a lot of energy talking about screening, condoms, and antibiotics. But the single most effective tool we have for preventing STD-related fertility damage in men is the HPV vaccine. And most men are not getting it.
The CDC recommends routine HPV vaccination for all boys starting at age 11 or 12, with catch-up vaccination through age 26. But as of 2023, only about 67% of boys in the US had received at least one dose, compared to 75% of girls. The gap is even wider for men over 18. Most men in their twenties and thirties have never been offered the vaccine. They do not know it exists for them.
HPV is not a bacteria. It does not respond to antibiotics. It is a virus that can persist in the male reproductive tract for years. The vaccine prevents the strains that cause 90% of HPV-related cancers and the majority of genital wart cases. But it also prevents the strains most associated with sperm damage. A 2020 study in Fertility and Sterility found that men who were vaccinated against HPV had sperm with higher motility and lower DNA fragmentation compared to unvaccinated men, even after controlling for other factors. The vaccine appears to protect not just against infection but against the downstream inflammatory effects that damage sperm.
If I could give one piece of practical advice to a man under 30, it would be this: talk to your doctor about the HPV vaccine. It is not just for women. It is not just for preventing cancer. It is one of the few interventions that can protect your fertility from a virus that has no cure and often has no symptoms.
What the Future Could Look Like
Let me paint a reasonable scenario based on the data we have now.
By 2035, we may see regional outbreaks of ceftriaxone-resistant gonorrhea in major urban centers. Treatment will shift to combination therapies or older, more toxic drugs. Some men will have to live with persistent infections for weeks or months while doctors cycle through treatment options. The rate of epididymitis and subsequent infertility in these populations will rise. We will see more men in their late twenties and early thirties showing up to fertility clinics with blocked reproductive tracts and no idea they ever had an STD.
The public health response will likely involve increased screening - testing every sexually active young man for chlamydia and gonorrhea at least once a year, regardless of symptoms. That is already recommended in some countries, but uptake in the US is low because men do not go to the doctor unless something hurts. We will need to change that norm.
On the positive side, new diagnostic tools are emerging. At-home STI test kits can detect chlamydia and gonorrhea from a urine sample with high accuracy. Several companies are working on multiplex PCR tests that screen for multiple pathogens at once, including trichomoniasis and Mycoplasma genitalium, another bacterium linked to fertility issues that is often overlooked. If these become cheap and widely available, men can test regularly without a doctor visit. That is the best bulwark against antibiotic-resistant infections: catch them early, treat them fast.
What You Can Do Right Now
Here is the actionable part. No fluff, no vague promises.
- Get tested annually. If you are sexually active and under 40, get tested for STDs at least once a year. Do not wait for symptoms. Most are silent. If you are trying to conceive with a partner, both of you should be tested before you start trying. That is not overkill. It is basic risk management.
- Get the HPV vaccine. If you are under 26, get it if you have not already. If you are between 26 and 45, talk to your doctor about whether it makes sense for you. The CDC approved catch-up vaccination for men up to 45 in 2019, but most providers do not proactively offer it.
- Finish your antibiotics. If you test positive for an STD, finish the entire course of antibiotics, even if symptoms disappear. Then get retested after treatment to confirm the infection cleared. With resistance increasing, a single round of antibiotics is no longer guaranteed to work. Follow-up testing is not optional.
None of this is alarmist. The research is clear about where we are heading. The question is whether enough men will hear it before the window closes.
This article is for educational purposes only and does not constitute medical advice. If you have concerns about your fertility or possible STI exposure, please consult a healthcare provider.
Frequently asked questions
can chlamydia cause male infertility even without symptoms
Yes, and that's what makes it particularly dangerous. Chlamydia can be carried for months or even years without any noticeable signs, while inflammation quietly causes scarring and blockages in the epididymis or vas deferens. A review in Human Reproduction Update found that men with a history of chlamydia had lower sperm motility and higher DNA fragmentation rates even after the infection had been successfully treated.
is gonorrhea becoming antibiotic resistant
It already has, and the situation is serious. Gonorrhea has developed resistance to penicillin, tetracycline, and fluoroquinolones, leaving ceftriaxone as the only reliable first-line treatment recommended by the CDC as of 2025. The UK Health Security Agency reported a 21% increase in gonorrhea cases in 2023 and detected strains with reduced susceptibility to ceftriaxone, and treatment failures have already been reported in Japan and Australia.
should men get the HPV vaccine for fertility protection
It's one of the most practical steps a man can take. A 2020 study in Fertility and Sterility found that vaccinated men had sperm with higher motility and lower DNA fragmentation compared to unvaccinated men. The CDC recommends routine vaccination starting at age 11 or 12, with catch-up vaccination available through age 26, and approved catch-up vaccination for men up to 45 in 2019.
how often should sexually active men get tested for STDs
The article recommends that sexually active men under 40 get tested at least once a year, even without symptoms, because the majority of STDs in men produce no noticeable signs. If you're trying to conceive, both partners should be tested before trying to start a family. At-home urine test kits that detect chlamydia and gonorrhea with high accuracy are now available and make regular testing easier without a doctor visit.